Live Breaking News & Updates on Ana Oaknin|Page 2

Stay updated with breaking news from Ana oaknin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The promise of novel FolRα-targeting antibody

Presented today by VHIO’s Ana Oaknin at the 2023 ASCO Annual Meeting, 2-6 June (Chicago, IL), updated dose expansion data of the STRO-002-GM1 global phase I study show promise of FolRα-targeting antibody drug conjugate (ADC) luveltamab tazevibulin in patients with recurrent FolRα-expressing epithelial ovarian cancer. ....

Israel General , United States , Craig Berman , Hatem Dokainish , David Omalley , Lin Liu , Carmen Garc , Lainie Martin , John Diaz , Jesus Garcia , Alexander Spira , Russell Schilder , Michael Palumbo , Christina Annunziata , Denise Uyar , Tanja Pejovic , John Moroney , Caixa Foundation , Hebron Institute Of Oncology , Severo Ochoa Center , Gynecological Malignancies Group , Research Centres Of Catalonia , Hebron University Hospital , Ana Oaknin , Principal Investigator , Hebron Institute ,

Sutro Biopharma, Inc.: Sutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion Study in Ovarian Cancer and the Initiation of the Phase 2/3 Pivotal Study REFRaME-O1

- Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab tazevibulin, or luvelta, in ovarian cancer, demonstrating ....

United States , Israel General , Comunidad Autonoma De Cataluna , Sutro Biopharma , Anne Borgman , Luveltamab Tazevibulin , Bristol Myers Squibb , Amy Bonanno , Astellas Pharma , Anniej Chang , American Society Of Clinical Oncology , Exchange Commission , Hebron University Hospital , Solebury Strategic Communications , Sutro Biopharma Inc , Hebron Institute Of Oncology , Clinical Oncology , Annual Meeting , Principal Investigator , Ana Oaknin , Gynecological Tumor Unit , Attending Physician , Principal Clinical Investigator , Gynecological Malignancies Group , Hebron Institute , Tumor Proportion Score ,

Study shows efficacy and safety of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

Updated dose expansion data of the phase I STRO-002-GM1 study have been presented today by Ana Oaknin, Principal Investigator of the Vall d'Hebron Institute of Oncology's (VHIO) Gynecological Malignancies Group, on the ground at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO), 2-6 June in Chicago, USA. ....

United States , Israel General , Lily Ramsey , Hebron Institute Of Oncology , Hebron University Hospital , Gynecological Malignancies Group , Ana Oaknin , Principal Investigator , Hebron Institute , American Society , Clinical Oncology , Medical Oncologist , Ovarian Cancer , Cell Proliferation ,

Sutro Biopharma Announces Oral Presentation at ASCO 2023

- Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab. ....

United States , Israel General , Comunidad Autonoma De Cataluna , Astellas Pharma , Anne Borgman , Anniej Chang , Sutro Biopharma , Bristol Myers Squibb , Luveltamab Tazevibulin , Amy Bonanno , Exchange Commission , Hebron Institute Of Oncology , Solebury Strategic Communications , Sutro Biopharma Inc , American Society Of Clinical Oncology , Hebron University Hospital , Clinical Oncology , Annual Meeting , Principal Investigator , Ana Oaknin , Gynecological Tumor Unit , Attending Physician , Principal Clinical Investigator , Gynecological Malignancies Group , Hebron Institute , Tumor Proportion Score ,

Sutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion Study in Ovarian Cancer and the Initiation of the Phase 2/3 Pivotal Study REFRaME-O1

Forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers. ....

United States , Israel General , Comunidad Autonoma De Cataluna , Astellas Pharma , Amy Bonanno , Luveltamab Tazevibulin , Anniej Chang , Sutro Biopharma , Anne Borgman , Bristol Myers Squibb , Exchange Commission , American Society Of Clinical Oncology , Hebron University Hospital , Hebron Institute Of Oncology , Sutro Biopharma Inc , Solebury Strategic Communications , Clinical Oncology , Annual Meeting , Principal Investigator , Ana Oaknin , Gynecological Tumor Unit , Attending Physician , Principal Clinical Investigator , Gynecological Malignancies Group , Hebron Institute , Tumor Proportion Score ,